Scilex Holding Company

SCLX NASDAQ Santé & Biotech États-Unis US80880W1062
7.00 $
7.65 %

Scilex Holding Company se concentre sur le développement et la commercialisation de thérapies non opioïdes pour le traitement de la douleur.

Performance & Momentum

6 Months 63.10 %
1 Year 9.23 %
3 Years 97.43 %
5 Years 97.97 %

Similar stocks to Scilex Holding Company

Anantys Community

Be the first to share your analysis on Scilex Holding Company.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases